Coloplast's Titan Prime inflatable penile prosthesis approved by FDA
The next-generation device will be available in the U.S. in late 2026, helping millions of men with erectile dysfunction.
See the latest news and media coverage for Coloplast. We track all announcements, press releases, and industry mentions in real time, all in one place.
Intimate healthcare solutions provider
coloplast.comLast updated
In short: Coloplast appointed Gavin Wood as CEO, secured FDA approval for its Titan Prime penile implant, and reported 6% organic growth in Q1 2026.
The next-generation device will be available in the U.S. in late 2026, helping millions of men with erectile dysfunction.
The company also reported 6% EBIT growth in constant currencies, reflecting increased product usage
He shares in a video what attracted him to Coloplast and excites him about the future. Welcome, Gavin!
The dressing's 3DFit Technology adapts to wound depth up to 2 cm, supports pressure injury prevention, allows inspection and reapplication, and may reduce waste and improve efficiency.
Coloplast's stock has fallen back by over 30 percent in the past year, and investors are hungry for good news. At Deutsche Bank, they expect the upcoming...
Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw a large decrease in short interest in the month of May. As of May 29th...
Danish stocks came under pressure after there were new attacks between Iran and the US, which has led investors to question whether...
Coloplast's next generation of inflatable penile implants, Titan Prime, has been approved by the U.S. health authorities. This appears from a...
Track Coloplast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Coloplast and other trending companies.